A novel approach to positron emission tomography in lung cancer

Susan D Moffatt-Bruce; Stephen P Povoski; Suhail Sharif; Nathan C Hall; Patrick Ross Jr; Morgan A Johnson; Edward W Martin Jr

doi:10.1016/j.athoracsur.2008.03.072

A novel approach to positron emission tomography in lung cancer

Ann Thorac Surg. 2008 Oct;86(4):1355-7. doi: 10.1016/j.athoracsur.2008.03.072.

Authors

Susan D Moffatt-Bruce¹, Stephen P Povoski, Suhail Sharif, Nathan C Hall, Patrick Ross Jr, Morgan A Johnson, Edward W Martin Jr

Affiliation

¹ Division of Cardiothoracic Surgery, Department of Surgery, Arthur G. James Cancer Hospital Columbus, Ohio, USA. susan.moffatt-bruce@osumc.edu

PMID: 18805196
DOI: 10.1016/j.athoracsur.2008.03.072

Abstract

18F-fluorodeoxyglucose positron emission tomography-computed tomography is integral to the staging of lung cancer. We describe the combined use of diagnostic preoperative 18F-fluorodeoxyglucose positron emission tomography-computed tomography, intraoperative 18F-fluorodeoxyglucose handheld gamma probe detection, and immediate postoperative 18F-fluorodeoxyglucose positron emission tomography-computed tomography patient and specimen imaging for improved staging and determination of adequacy of mediastinal lymph node dissection.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Biopsy, Needle
Fluorodeoxyglucose F18*
Follow-Up Studies
Gamma Cameras
Humans
Lung Neoplasms / diagnostic imaging*
Lung Neoplasms / pathology
Lung Neoplasms / surgery*
Lymph Nodes / diagnostic imaging
Lymph Nodes / pathology*
Male
Neoplasm Staging
Pneumonectomy / methods
Positron-Emission Tomography / methods*
Postoperative Care / methods
Preoperative Care / methods
Sensitivity and Specificity
Thoracotomy / methods
Treatment Outcome
Whole Body Imaging

Substances

Fluorodeoxyglucose F18